Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted TherapyRepresentative category illustration – no product packaging is shown.Palladia (Toceranib): Approved Canine Mast Cell Tumor Targeted Therapy
Palladia is an FDA-approved prescription veterinary tyrosine kinase inhibitor for treatment of Patnaik grade II or III recurrent canine cutaneous mast cell tumors, with or without regional lymph-node…
Read moreNamed profile Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine LymphomaRepresentative category illustration – no product packaging is shown.Laverdia (Verdinexor): FDA-Approved Oral Therapy for Canine Lymphoma
Verdinexor is an oral prescription antineoplastic for certain dogs with lymphoma. FDA announced full approval in January 2026 after the product's earlier conditional-approval pathway; publication should use the…
Read more
Palliative Care Plan: Concurrent Comfort From Diagnosis Onward
Palliative care focuses on comfort and function and can begin at diagnosis while tumor-directed treatment continues. Hospice is a later, more intensive form of comfort-focused care; neither means…
Read moreTyrosine Kinase Inhibitors: A Class-Level Monitoring Framework
Tyrosine kinase inhibitors are not one interchangeable drug class; target profile, label, evidence, dosing, monitoring, and adverse effects differ by product and patient.
Read moreImatinib in Canine Mast Cell Tumor Care: Extra-Label Evidence Review
Imatinib has published canine mast cell tumor experience but is not interchangeable with veterinary-labeled TKIs and requires specialist, legal, formulation, and evidence review.
Read moreNamed profile Masivet (Masitinib): EU/UK-Authorised Targeted Therapy for c-KIT-Mutated Canine Mast Cell TumorsRepresentative category illustration – no product packaging is shown.Masivet (Masitinib): EU/UK-Authorised Targeted Therapy for c-KIT-Mutated Canine Mast Cell Tumors
Masitinib is an oral canine TKI with an EMA veterinary authorization for a defined mast cell tumor setting; the current regional label governs eligibility and monitoring.
Read more
Named profile Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor TherapyRepresentative category illustration – no product packaging is shown.Stelfonta (Tigilanol Tiglate): Intratumoral Canine Mast Cell Tumor Therapy
Stelfonta is an FDA-approved intratumoral treatment for narrowly defined canine mast cell tumors, with important current warnings about degranulation, wounds, pain, tissue loss, amputation, and death.
Read more
Breakthrough Pain Plan for Advanced Cancer
A breakthrough-pain plan defines what sudden worsening looks like, which prescribed rescue action is available, and when home care is no longer safe.
Read moreBreathing Distress: Comfort Planning Without Delaying Emergency Care
Labored breathing is an emergency sign; a palliative plan can reduce avoidable stress but cannot make unsupervised home treatment safe.
Read moreBleeding-Crisis Planning for Vascular or Ulcerated Tumors
Families caring for a bleeding-prone mass need written steps for minor surface bleeding, transport, transfusion decisions, and catastrophic hemorrhage before a crisis occurs.
Read moreVeterinary Hospice at Home: Services, Limits, and Daily Plan
Home hospice is active veterinary care for a terminal or progressive condition, combining symptom treatment, caregiver support, crisis preparation, and a plan for death.
Read moreQuality-of-Life Scales: A Conversation Tool, Not a Verdict
A quality-of-life tool can make daily observations consistent and prompt discussion, but no total score can decide alone whether a pet is comfortable or when death should occur.
Read more